MigraineMind research summary
Changes in Migraine-Related Outcomes and Functioning at 1 Year: Results of the Longitudinal OVERCOME (US) Study.
Neurol Ther | 2026
Observational studySummary
Migraine is a common neurological disorder that significantly affects quality of life. Understanding changes in migraine outcomes over time can improve clinical care. The OVERCOME study surveyed 11,634 adults with migraine in the United States. Participants completed surveys at baseline and one year later. Migraine status was classified as "overall improved," "overall worsened," or "no net change." Results showed that 40% improved, 24% worsened, and 36% had no net change. The improved group reported fewer monthly headache days, lower MIDAS scores, and better quality of life. They also had less impact on work and less stigma. In contrast, the worsened group experienced more headache days and increased disability. They faced greater stigma and required more medications. Overall, the study highlights the significant variations in migraine impact on patients’ lives over time and the need for tailored treatment approaches to improve outcomes. Clinical relevance: This research highlights the diverse effects of migraine on patients' lives, emphasizing the importance of personalized treatment strategies.
Key Learning Points
- Migraine significantly impacts quality of life, making effective management essential for those affected.
- About 40% of migraine patients reported improvement over a year, indicating potential for positive change with proper treatment.
- Patients who improved experienced fewer headache days and better overall quality of life compared to those who worsened.
- The study revealed that 24% of participants experienced worsening symptoms, highlighting the need for ongoing assessment and adjustment of treatment plans.
- Tailored treatment approaches are crucial for addressing the varying effects of migraine on individuals' daily lives and work.
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.